Zheng-Chao Tu

ORCID: 0000-0003-4074-7769
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Microtubule and mitosis dynamics
  • Cancer-related Molecular Pathways
  • Quinazolinone synthesis and applications
  • Microbial Natural Products and Biosynthesis
  • Ubiquitin and proteasome pathways
  • Protein Kinase Regulation and GTPase Signaling
  • Melanoma and MAPK Pathways
  • Protein Tyrosine Phosphatases
  • Cell Adhesion Molecules Research
  • PI3K/AKT/mTOR signaling in cancer
  • Autophagy in Disease and Therapy
  • Cancer Mechanisms and Therapy
  • Photosynthetic Processes and Mechanisms
  • Sirtuins and Resveratrol in Medicine
  • Monoclonal and Polyclonal Antibodies Research
  • Glycosylation and Glycoproteins Research
  • Biochemical and Molecular Research
  • Synthesis and biological activity

Guangzhou Institutes of Biomedicine and Health
2014-2019

Chinese Academy of Sciences
2014-2019

A series of 2-amino-2,3-dihydro-1H-indene-5-carboxamides were designed and synthesized as new selective discoidin domain receptor 1 (DDR1) inhibitors. One the representative compounds, 7f, bound with DDR1 a Kd value 5.9 nM suppressed kinase activity an half-maximal (50%) inhibitory concentration 14.9 nM. 7f potently inhibited collagen-induced signaling epithelial–mesenchymal transition, dose-dependently colony formation pancreatic cancer cells, exhibited promising in vivo therapeutic...

10.1021/acs.jmedchem.9b00365 article EN cc-by Journal of Medicinal Chemistry 2019-07-16

A series of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides were designed as the first class highly selective ZAK inhibitors. The representative compound 3h strongly inhibits kinase activity with an IC50 3.3 nM and dose-dependently suppresses activation downstream signals in vitro vivo, while it is significantly less potent for majority 403 nonmutated kinases evaluated. Compound also exhibits orally therapeutic effects on cardiac hypertrophy a spontaneous hypertensive rat model.

10.1021/acs.jmedchem.7b00572 article EN Journal of Medicinal Chemistry 2017-06-06

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) has the potential to directly limit NAD production in cancer cells and is an effective strategy for treatment. Using a structure-based strategy, we have designed new class potent small-molecule inhibitors NAMPT. Several compounds showed promising antiproliferative activities vitro. (E)-N-(5-((4-(((2-(1H-Indol-3-yl)ethyl)(isopropyl)amino)methyl)phenyl)amino)pentyl)-3-(pyridin-3-yl)acrylamide, 30, bearing indole moiety, IC50 25.3 nM...

10.1021/acs.jmedchem.6b00324 article EN Journal of Medicinal Chemistry 2016-05-25
Coming Soon ...